Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease

被引:12
|
作者
Franzmeier, Nicolai [1 ,2 ,3 ,4 ]
Dehsarvi, Amir [1 ]
Steward, Anna [1 ]
Biel, Davina [1 ]
Dewenter, Anna [1 ]
Roemer, Sebastian Niclas [1 ]
Wagner, Fabian [1 ]
Gross, Mattes [1 ,5 ]
Brendel, Matthias [2 ,5 ]
Moscoso, Alexis [3 ,4 ]
Arunachalam, Prithvi [3 ,4 ]
Blennow, Kaj [3 ,4 ,6 ]
Zetterberg, Henrik [3 ,4 ,6 ,7 ,8 ,9 ,10 ]
Ewers, Michael [1 ,11 ]
Schoell, Michael [3 ,4 ,12 ,13 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res ISD, Munich, Germany
[2] Munich Cluster Syst Neurol SyNergy, Munich, Germany
[3] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden
[4] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Dept Psychiat & Neurochem, Gothenburg, Sweden
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[6] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[7] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England
[8] UCL, UK Dementia Res Inst, London, England
[9] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China
[10] Univ Wisconsin, Wisconsin Alzheimers Dis Res Ctr, Sch Med & Publ Hlth, Madison, WI USA
[11] German Ctr Neurodegenerat Dis DZNE, Munich, Germany
[12] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
[13] UCL, Queen Sq Inst Neurol, Dementia Res Ctr, London, England
基金
瑞典研究理事会; 欧盟地平线“2020”;
关键词
MESSENGER-RNA; MOUSE MODEL; HYPERACTIVITY; ANTIBODIES; RELEASE; NEURONS; BETA;
D O I
10.1038/s41467-023-44374-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In Alzheimer's disease, amyloid-beta (A beta) triggers the trans-synaptic spread of tau pathology, and aberrant synaptic activity has been shown to promote tau spreading. A beta induces aberrant synaptic activity, manifesting in increases in the presynaptic growth-associated protein 43 (GAP-43), which is closely involved in synaptic activity and plasticity. We therefore tested whether A beta-related GAP-43 increases, as a marker of synaptic changes, drive tau spreading in 93 patients across the aging and Alzheimer's spectrum with available CSF GAP-43, amyloid-PET and longitudinal tau-PET assessments. We found that (1) higher GAP-43 was associated with faster A beta-related tau accumulation, specifically in brain regions connected closest to subject-specific tau epicenters and (2) that higher GAP-43 strengthened the association between A beta and connectivity-associated tau spread. This suggests that GAP-43-related synaptic changes are linked to faster A beta-related tau spread across connected regions and that synapses could be key targets for preventing tau spreading in Alzheimer's disease. Trans-synaptic tau spread drives neurodegeneration in Alzheimer's disease. This study shows that GAP-43, a marker of synaptic abnormality, is linked to faster tau spread, showing that synaptic changes may contribute to tau spreading in Alzheimer's disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
    Jon B. Toledo
    Ane Korff
    Leslie M. Shaw
    John Q. Trojanowski
    Jing Zhang
    Acta Neuropathologica, 2013, 126 : 683 - 697
  • [42] CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
    Dong, Ruocheng
    Darst, Burcu F.
    Deming, Yuetiva
    Ma, Yue
    Lu, Qiongshi
    Zetterberg, Henrik
    Blennow, Kaj
    Carlsson, Cynthia M.
    Johnson, Sterling C.
    Asthana, Sanjay
    Engelman, Corinne D.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [43] Cerebrospinal protein tau is elevated in early Alzheimer's disease
    Riemenschneider, M
    Buch, K
    Schmolke, M
    Kurz, A
    Guder, WG
    NEUROSCIENCE LETTERS, 1996, 212 (03) : 209 - 211
  • [44] CSF P-tau 231 as Biomarker in Alzheimer's Disease
    Mukherjee, Adreesh
    Biswas, Atanu
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (06) : 995 - 996
  • [45] CSF tau markers are correlated with hippocampal volume in Alzheimer's disease
    de Souza, Leonardo C.
    Chupin, Marie
    Lamari, Foudil
    Jardel, Claude
    Leclercq, Delphine
    Colliot, Olivier
    Lehericy, Stephane
    Dubois, Bruno
    Sarazin, Marie
    NEUROBIOLOGY OF AGING, 2012, 33 (07) : 1253 - 1257
  • [46] CSF p-Tau levels in the prediction of Alzheimer's disease
    Kandimalla, Ramesh J. L.
    Prabhakar, Sudesh
    Wani, Willayat Yousuf
    Kaushal, Alka
    Gupta, Nidhi
    Sharma, Deep Raj
    Grover, V. K.
    Bhardwaj, Neerja
    Jain, Kajal
    Gill, Kiran Dip
    BIOLOGY OPEN, 2013, 2 (11): : 1119 - 1124
  • [47] Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease
    Meredith, Jere E., Jr.
    Sankaranarayanan, Sethu
    Guss, Valerie
    Lanzetti, Anthony J.
    Berisha, Flora
    Neely, Robert J.
    Slemmon, J. Randall
    Portelius, Erik
    Zetterberg, Henrik
    Blennow, Kaj
    Soares, Holly
    Ahlijanian, Michael
    Albright, Charles F.
    PLOS ONE, 2013, 8 (10):
  • [48] Understanding How CSF Tau Concentrations Reveal Alzheimer's Disease
    Triana-Baltzer, Gallen
    Slemmon, Randy
    Shapiro, Alice
    Mercken, Marc
    Streffer, Johannes
    Zetterberg, Henrik
    Blennow, Kaj
    Kolb, Hartmuth
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S362 - S363
  • [49] Understanding How CSF Tau Fragmentation Reveals Alzheimer's Disease
    Triana-Baltzer, Gallen
    Slemmon, Randy
    Shapiro, Alice
    Mercken, Marc
    Streffer, Johannes
    Zetterberg, Henrik
    Blennow, Kaj
    Kolb, Hartmuth
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 160S - 160S
  • [50] Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer’s dementia continuum: an [18 F] AV-45 study
    Rezvan Nemati
    Ahmadreza Sohrabi-Ashlaghi
    Parsa Saberian
    Mohammad Sadeghi
    Sajjad Mardani
    Amir Sina Jafari Hossein Abadi
    Ali Yaghoobpoor
    Atefeh Heydari
    Niloofar Khoshroo
    Yassin Rahnama
    Mahsa Mayeli
    Hamide Nasiri
    BMC Neurology, 25 (1)